These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 47841)
1. Cell-mediated immunity to moloney sarcoma virus in mice. I. Analysis of antigens responsible for lymphocyte stimulation in regressor mice. Knight RA; Gorczynski RM Int J Cancer; 1975 Jan; 15(1):48-58. PubMed ID: 47841 [TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors. Gorczynski RM; Knight RA Eur J Immunol; 1975 Feb; 5(2):148-55. PubMed ID: 1086221 [TBL] [Abstract][Full Text] [Related]
3. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s). Lamon EW; Skurzak HM; Andersson B; Whitten HD; Klein E J Immunol; 1975 Apr; 114(4):1171-6. PubMed ID: 1117138 [TBL] [Abstract][Full Text] [Related]
4. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens. Ng AK; Ames RS; McIntire RK; Herberman RB Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218 [TBL] [Abstract][Full Text] [Related]
5. The lymphocyte response to a primary viral neoplasm (MSV) through its entire course in BALB-c mice. Lamon EW; Skurzak HM; Klein E Int J Cancer; 1972 Nov; 10(3):581-8. PubMed ID: 4128689 [No Abstract] [Full Text] [Related]
6. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas. Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527 [TBL] [Abstract][Full Text] [Related]
8. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas. Leclerc JC; Gomard E; Levy JP Int J Cancer; 1972 Nov; 10(3):589-601. PubMed ID: 4128690 [No Abstract] [Full Text] [Related]
9. Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes. Chieco-Bianchi L; Colombatti A; Collavo D; Sendo F; Aoki T; Fischinger PJ J Exp Med; 1974 Nov; 140(5):1162-79. PubMed ID: 4608945 [TBL] [Abstract][Full Text] [Related]
10. The lymphocyte response to primary Moloney sarcoma virus tumors in BALB-c mice. Definition of the active subpopulations at different times after infection. Lamon EW; Wigzel H; Klein E; Andersson B; Skurzak HM J Exp Med; 1973 Jun; 137(6):1472-93. PubMed ID: 4709269 [TBL] [Abstract][Full Text] [Related]
11. Tumors induced by progressor sarcoma virus (Moloney) in mice: growth in the presence of an immune response and isolation of autonomously growing cells. Weiland E; Mussgay M Arch Virol; 1980; 66(1):1-10. PubMed ID: 7436738 [TBL] [Abstract][Full Text] [Related]
12. A non-virion surface antigen on Moloney sarcoma virus-transformed non-producer and producer cells. Hunsmann G; Weiland E; Mussgay M; Schneider J J Gen Virol; 1980 Aug; 49(2):375-84. PubMed ID: 6255072 [TBL] [Abstract][Full Text] [Related]
13. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. Flyer DC; Burakoff SJ; Faller DV J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792 [TBL] [Abstract][Full Text] [Related]
14. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system. Harada M; Pearson G; Redmon L; Winters E; Kasuga S J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675 [TBL] [Abstract][Full Text] [Related]
15. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors. Biasi G; Saggin L; Dazzi F; De Rossi A; Collavo D J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589 [TBL] [Abstract][Full Text] [Related]
16. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors. Lamon EW; Anderson B; Wigzell H; Fenyö EM; Klein E Int J Cancer; 1974 Jan; 13(1):91-104. PubMed ID: 4594340 [No Abstract] [Full Text] [Related]
17. Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: differential activity of IgG and IgM with different subpopulations of lymphocytes. Lamon EW; Shaw MW; Goodson S; Lidin B; Walia AS; Fuson EW J Exp Med; 1977 Feb; 145(2):302-13. PubMed ID: 833543 [TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction. Senik A; Gomard E; Plata F; Levy JP Int J Cancer; 1973 Jul; 12(1):233-41. PubMed ID: 4133585 [No Abstract] [Full Text] [Related]
19. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). II. Detection of cell-surface antigens by indirect membrane immunofluorescence. Jones DB; Moore M Br J Cancer; 1974 Feb; 29(2):158-67. PubMed ID: 4133783 [TBL] [Abstract][Full Text] [Related]
20. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus. Wood GW Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]